Assessing and Treating Patients with Impulsivity, Compulsivity, and Addiction.

Assessing and Treating Patients with Impulsivity, Compulsivity, and Addiction.

Assessing and Treating Patients with Impulsivity, Compulsivity, and Addiction.

Introduction

This assignment is a case study about Mrs. Perez, a 53-year-old with a diagnosis of gambling disorder, alcohol use disorder. The client in this case study uncontrollable alcohol intake and addiction to alcohol, as well as increasing smoking of tobacco. The findings from the MSE indicated that her mood was sad, avoided eye contact, well-oriented and alert, clear and coherent speech, and both judgment and insight intact. However, her impulse control was impaired. Gambling disorder is characterized by persistent and repetitive maladaptive behavior where a person is preoccupied with gambling. Gambling leads the individual gambling with bigger amounts of money to achieve the expected excitement, inability to stop gambling, continue to gamble even after suffering from bog financial losses, lying to family members, among others (Ferrara et al., 2018).Assessing and Treating Patients with Impulsivity, Compulsivity, and Addiction.

ORDER  HERE A PLAGIARISM-FREE PAPER HERE

As a result, gambling may affect interpersonal relationships, education, and work. Alcohol use disorder is characterized by the inability of an individual to control or manage alcohol intake despite the desire to reduce or stop the alcohol intake, and the alcohol drinking having an adverse effect on an individual’s education, work, or relationships (Knox et al., 2019). Since the diagnosis for Mrs. Perez is gambling disorder, alcohol use disorder, this paper will discuss her appropriate treatment choices and outline the ethical principles applied during her treatment.Assessing and Treating Patients with Impulsivity, Compulsivity, and Addiction.

Decision Point One

The appropriate decision is for the client to start Naltrexone (Vivitrol) injection, 380 mg intramuscularly in the gluteal region every 4 weeks. Naltrexone was prescribed because it is a competitive antagonist for alcohol receptors and hence the medication hinders agonist-induced effects. The medication is also effective in reducing the desire to drink alcohol and its efficacy in treating efficacy has been shown in various studies (Alanis-Hirsch et al., 2016). Assessing and Treating Patients with Impulsivity, Compulsivity, and Addiction.In addition, administration of the medication through injective will improve her treatment adherence and it has minimal side effects. The reason why Antabuse was not chosen is due to its several side effects like dyspnea, vomiting, coma, palpitations, headache, among other serious side effects. Additionally, Antabuse is associated with a high non-adherence rate and a high risk of toxicity. Assessing and Treating Patients with Impulsivity, Compulsivity, and Addiction.The reason why Campral was not considered is because the medication should be combined with a psychotherapy treatment to ensure adequate recovery from alcohol addiction. Moreover, Campral should not be used while the patient is still taking alcohol, yet Mrs. Perez has not yet stopped taking alcohol.Assessing and Treating Patients with Impulsivity, Compulsivity, and Addiction.

Prescribing naltrexone injection expected that the client would stop craving for alcohol, and eventually stop alcohol intake. It was also expected that the gambling would reduce. Evidence demonstrates that Naltrexone is effective in reducing the desire to drink alcohol and reducing the desire to gamble (Ward et al., 2018). It is also expected that she would adhere to treatment and she would also not experience major side effects.Assessing and Treating Patients with Impulsivity, Compulsivity, and Addiction.

As expected, after four weeks Mrs. Perez reported that she had stopped taking alcohol and also her desire to gamble had reduced, but she was still using large sums of money in the casino. She also reported an increased need to smoke and anxiety, which is the medication’s side effect (anxiety) (Ward et al., 2018).Assessing and Treating Patients with Impulsivity, Compulsivity, and Addiction.

During Mr. Perez’s treatment, informed consent was sought to ensure she agreed to receive the treatment after being provided with adequate information about all the available treatment options. Additionally, the privacy and confidentiality of her information and hence her diagnosis and treatment were not revealed to any other person, without her authorization (Darby & Weinstock, 2018).Assessing and Treating Patients with Impulsivity, Compulsivity, and Addiction.

Decision Point Two

The treatment options for decision point two are the a